findings

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement –– Strong activity observed…

1 week ago

New 2026 L&D Report Shows AI Adoption Outpacing Workforce Readiness, Critical Thinking, Leadership, and Mentorship Needs

CALGARY, Alberta, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Together, the mentorship and peer-to-peer learning platform from Absorb Software, today released…

2 weeks ago

Cribl Supercharges Incident Response in Amazon Security Hub with Open Cybersecurity Schema Framework (OCSF) Support

Enhanced capability in Cribl Stream transforms disparate security findings into a standardized format, accelerating threat correlation and resolution December 02,…

2 weeks ago

Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial

Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its October 27th Registered Direct Offering November 24, 2025…

3 weeks ago

IBM Study: Chief Data Officers Redefine Strategies as AI Ambitions Outpace Readiness

81% of Chief Data Officers surveyed prioritize investments that accelerate AI capabilities and initiatives. 78% of surveyed leaders cite leveraging…

1 month ago

Zscaler ThreatLabz Reveals 67% Jump in Android Malware and 40% of IoT Attacks Target Critical Industries and Hybrid Work

Key Findings: Critical infrastructure in the energy sector experienced a 387% increase in attacks compared to the previous yearIndia continues…

1 month ago

Baylor Genetics to Highlight Genetic Testing Use Cases and Advancements in Rare Disease at The National Society of Genetic Counselors 44th Annual Conference

HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, will…

1 month ago

ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors

SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings…

2 months ago

World’s Leading Nutrition Researchers Discuss Future Lines of Research on Nuts and Dried Fruit at NUTS 2025

REUS, Spain, Oct. 22, 2025 /PRNewswire/ -- Leading health researchers from around the world have identified new priorities and directions…

2 months ago

Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer

Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients1 New findings from this investigational…

2 months ago